Your browser doesn't support javascript.
loading
Radiation induces dynamic changes to the T cell repertoire in renal cell carcinoma patients.
Chow, Jacky; Hoffend, Nicholas C; Abrams, Scott I; Schwaab, Thomas; Singh, Anurag K; Muhitch, Jason B.
Afiliación
  • Chow J; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263.
  • Hoffend NC; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263.
  • Abrams SI; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263.
  • Schwaab T; Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263.
  • Singh AK; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263.
  • Muhitch JB; Department of Radiation Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263.
Proc Natl Acad Sci U S A ; 117(38): 23721-23729, 2020 09 22.
Article en En | MEDLINE | ID: mdl-32900949
Clinical studies combining radiation and immunotherapy have shown promising response rates, strengthening efforts to sensitize tumors to immune-mediated attack. Thus, there is an ongoing surge in trials using preconditioning regimens with immunotherapy. Yet, due to the scarcity of resected tumors treated in situ with radiotherapy, there has been little investigation of radiation's sole contributions to local and systemic antitumor immunity in patients. Without this access, translational studies have been limited to evaluating circulating immune subsets and systemic remodeling of peripheral T cell receptor repertoires. This constraint has left gaps in how radiation impacts intratumoral responses and whether tumor-resident T cell clones are amplified following treatment. Therefore, to interrogate the immune impact of radiation on the tumor microenvironment and test the hypothesis that radiation initiates local and systemic expansion of tumor-resident clones, we analyzed renal cell carcinomas from patients treated with stereotactic body radiation therapy. Transcriptomic comparisons were evaluated by bulk RNA sequencing. T cell receptor sequencing monitored repertoires during treatment. Pathway analysis showed radiation-specific enrichment of immune-related processes, and T cell receptor sequencing revealed increased clonality in radiation-treated tumors. The frequency of identified, tumor-enriched clonotypes was tracked across serial blood samples. We observed increased abundance of tumor-enriched clonotypes at 2 wk postradiation compared with pretreatment levels; however, this expansion was not sustained, and levels contracted toward baseline by 4 wk posttreatment. Taken together, these results indicate robust intratumoral immune remodeling and a window of tumor-resident T cell expansion following radiation that may be leveraged for the rational design of combinatorial strategies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Linfocitos T / Radiocirugia / Transcriptoma / Neoplasias Renales Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma de Células Renales / Linfocitos T / Radiocirugia / Transcriptoma / Neoplasias Renales Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos